{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:44:32Z","timestamp":1773290672221,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jprasurg.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Plastic, Reconstructive &amp; Aesthetic Surgery"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.bjps.2022.11.038","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T13:35:52Z","timestamp":1669296952000},"page":"117-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Intralesional steroid in the era of propranolol for infantile hemangioma\u2014Do we need it?"],"prefix":"10.1016","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3514-0225","authenticated-orcid":false,"given":"Anand","family":"Pandey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anurag","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitin","family":"Pant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4419-214X","authenticated-orcid":false,"given":"Sudhir","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiledar","family":"Rawat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjps.2022.11.038_bib0001","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0140-6736(16)00645-0","article-title":"Infantile haemangioma","volume":"390","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.bjps.2022.11.038_bib0002","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1056\/NEJMc0708819","article-title":"Propranolol for severe hemangiomas of infancy","volume":"358","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bjps.2022.11.038_bib0003","doi-asserted-by":"crossref","first-page":"e12595","DOI":"10.1111\/dth.12595","article-title":"A self-controlled study of intralesional injection of diprospan combined with topical timolol cream for treatment of thick superficial infantile hemangiomas","volume":"31","author":"Xu","year":"2018","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.bjps.2022.11.038_bib0004","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/pde.14163","article-title":"Propranolol-resistant infantile hemangioma successfully treated with sirolimus","volume":"37","author":"D\u00e1vila-Osorio","year":"2020","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.bjps.2022.11.038_bib0005","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/bjd.12417","article-title":"Propranolol-resistant infantile haemangiomas","volume":"169","author":"Causs\u00e9","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.bjps.2022.11.038_bib0006","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jpedsurg.2008.10.038","article-title":"Twenty years' experience of steroids in infantile hemangioma: A developing country's perspective","volume":"44","author":"Pandey","year":"2009","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.bjps.2022.11.038_bib0007","series-title":"Hemangiomas and vascular malformations","first-page":"67","article-title":"Hemangiomas: Clinical pictures","author":"Cordisco","year":"2015"},{"key":"10.1016\/j.bjps.2022.11.038_bib0008","series-title":"Hemangiomas and vascular malformations","first-page":"97","article-title":"propranolol and beta-blockers in the medical treatment of infantile hemangiomas","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2015"},{"key":"10.1016\/j.bjps.2022.11.038_bib0009","first-page":"205","article-title":"Infantile periocular hemangioma","volume":"12","author":"Tavakoli","year":"2017","journal-title":"J Ophthalmic Vis Res"},{"key":"10.1016\/j.bjps.2022.11.038_bib0010","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3892\/mco.2021.2318","article-title":"Propranolol vs. steroids in the treatment of infantile hemangiomas: A meta-analysis","volume":"15","author":"You","year":"2021","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.bjps.2022.11.038_bib0011","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.bjps.2010.07.009","article-title":"Propranolol as first-line treatment for rapidly proliferating infantile haemangiomas","volume":"64","author":"Holmes","year":"2011","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.bjps.2022.11.038_bib0012","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-3866","article-title":"Efficacy of propranolol between 6 and 12 months of age in high-risk infantile hemangioma","volume":"142","author":"Baselga","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.bjps.2022.11.038_bib0013","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/1346-8138.14316","article-title":"Thirty-two Japanese cases of infantile hemangiomas treated with oral propranolol","volume":"45","author":"Kagami","year":"2018","journal-title":"J Dermatol"},{"key":"10.1016\/j.bjps.2022.11.038_bib0014","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s12098-017-2355-8","article-title":"Vascular anomalies: A pediatric surgeon's perspective","volume":"84","author":"Gupta","year":"2017","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.bjps.2022.11.038_bib0015","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.ijom.2018.03.024","article-title":"Role of intralesional bleomycin and intralesional triamcinolone therapy in residual haemangioma following propranolol","volume":"47","author":"Pandey","year":"2018","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.bjps.2022.11.038_bib0016","article-title":"Interventions for infantile haemangiomas of the skin","volume":"4","author":"Novoa","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bjps.2022.11.038_bib0017","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2147\/DDDT.S134808","article-title":"Propranolol therapy for infantile hemangioma: Our experience","volume":"11","author":"Zhang","year":"2017","journal-title":"Drug Des Devel Ther."},{"key":"10.1016\/j.bjps.2022.11.038_bib0018","doi-asserted-by":"crossref","first-page":"e14346","DOI":"10.1097\/MD.0000000000014346","article-title":"Associations between short-term efficacy and clinical characteristics of infantile hemangioma treated by propranolol","volume":"98","author":"Wu","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bjps.2022.11.038_bib0019","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.oooo.2019.04.014","article-title":"Therapeutic efficacy of propranolol for infantile hemangiomas","volume":"128","author":"Wu","year":"2019","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.bjps.2022.11.038_bib0020","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/pde.13816","article-title":"Topical timolol as adjunct therapy to shorten oral propranolol therapy for infantile hemangiomas","volume":"36","author":"Mannschreck","year":"2019","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.bjps.2022.11.038_bib0021","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.36849\/JDD.2020.5009","article-title":"Evaluation of clinical properties and treatment responses of infantile hemangioma","volume":"19","author":"Yildirimcakar","year":"2020","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.bjps.2022.11.038_bib0022","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1525-1470.2011.01345.x","article-title":"Propranolol for infantile hemangiomas","volume":"28","author":"Bagazgoitia","year":"2011","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.bjps.2022.11.038_bib0023","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1177\/0009922811405517","article-title":"\u03b2-blockers for infantile hemangiomas: A single-institution experience","volume":"50","author":"Blatt","year":"2011","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.bjps.2022.11.038_bib0024","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jpedsurg.2011.10.058","article-title":"Propranolol treatment of infantile hemangioma: Clinical and radiologic evaluations","volume":"47","author":"Talaat","year":"2012","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.bjps.2022.11.038_bib0025","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1097\/SCS.0000000000004152","article-title":"Intralesional bleomycin injection for propranolol-resistant hemangiomas","volume":"29","author":"Chang","year":"2018","journal-title":"J Craniofac Surg"},{"key":"10.1016\/j.bjps.2022.11.038_bib0026","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/jpc.12600","article-title":"Infantile haemangiomas that failed treatment with propranolol: Clinical and histopathological features","volume":"50","author":"Phillips","year":"2014","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.bjps.2022.11.038_bib0027","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/ped.13830","article-title":"Infantile hemangioma: Efficacy of low-dose propranolol and of intralesional bleomycin injection for propranolol non-response","volume":"61","author":"D\u00fczenli Kar","year":"2019","journal-title":"Pediatr Int"},{"key":"10.1016\/j.bjps.2022.11.038_bib0028","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/jamafacial.2017.0197","article-title":"Modern management of nasal hemangiomas","volume":"19","author":"Keller","year":"2017","journal-title":"JAMA Facial Plast Surg"},{"key":"10.1016\/j.bjps.2022.11.038_bib0029","doi-asserted-by":"crossref","first-page":"733e","DOI":"10.1097\/PRS.0b013e318245e739","article-title":"Comparison of efficacy of intralesional bleomycin and oral propanolol in management of hemangiomas","volume":"129","author":"Thayal","year":"2012","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.bjps.2022.11.038_bib0030","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.bjps.2010.06.010","article-title":"Low-dose propranolol for infantile haemangioma","volume":"64","author":"Tan","year":"2011","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.bjps.2022.11.038_bib0031","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/jamadermatol.2018.0617","article-title":"Intralesional deoxycholic acid treatment for fibrofatty residua of involuted infantile hemangiomas: A novel therapeutic approach","volume":"154","author":"Cardis","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.bjps.2022.11.038_bib0032","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.2147\/OPTH.S153121","article-title":"Combined oral propranolol with intralesional injection of triamcinolone acetonide in treatment of infantile periocular hemangiomas","volume":"11","author":"Alsmman","year":"2017","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.bjps.2022.11.038_bib0033","doi-asserted-by":"crossref","first-page":"e16986","DOI":"10.1097\/MD.0000000000016986","article-title":"Intralesional injection of triamcinolone acetonide for cavernous hemangiomas: A case report","volume":"98","author":"Wang","year":"2019","journal-title":"Medicine (Baltimore)"}],"container-title":["Journal of Plastic, Reconstructive &amp; Aesthetic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1748681522006714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1748681522006714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T20:51:27Z","timestamp":1761684687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1748681522006714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":33,"alternative-id":["S1748681522006714"],"URL":"https:\/\/doi.org\/10.1016\/j.bjps.2022.11.038","relation":{},"ISSN":["1748-6815"],"issn-type":[{"value":"1748-6815","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intralesional steroid in the era of propranolol for infantile hemangioma\u2014Do we need it?","name":"articletitle","label":"Article Title"},{"value":"Journal of Plastic, Reconstructive & Aesthetic Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjps.2022.11.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}